New Digital Treatments for Depression: Apps Like Rejoyn
Depression care is evolving—no longer limited to therapy or medication alone. Digital therapeutics, like the FDA‑cleared app Rejoyn, now offer evidence-based tools you can use daily on your phone. This guide explains how these apps work, who they're for, and why they matter.
What Is Rejoyn?
Rejoyn is the first smartphone-based prescription digital therapeutic cleared by the FDA for adults with major depressive disorder aged 22+, used alongside antidepressants and therapy :contentReference[oaicite:3]{index=3}.
How Does It Work?
- Six-week program with daily CBT-based lessons.
- Includes “Emotional Faces Memory Task”—identifying and remembering facial expressions to exercise brain regions like the amygdala and prefrontal cortex :contentReference[oaicite:4]{index=4}.
- Designed to rewire brain circuits to manage emotions more effectively.
How Effective Is It?
- Clinical trials show symptom relief comparable to or better than placebo apps :contentReference[oaicite:5]{index=5}.
- Real-world use saw half of users showing measurable improvement by week 10 :contentReference[oaicite:6]{index=6}.
- Higher adherence linked to stronger outcomes :contentReference[oaicite:7]{index=7}.
Why It Matters
Millions lack access to timely therapy. Digital tools offer:
- 24/7 availability without travel.
- Lower cost and stigma-free access :contentReference[oaicite:8]{index=8}.
- Supports and enhances traditional treatment.
Other Digital Therapies on the Rise
- Chatbot-guided CBT apps like Wysa showing positive improvements :contentReference[oaicite:9]{index=9}.
- FDA-approved video game therapy for ADHD, and VR-based depression therapy under research :contentReference[oaicite:10]{index=10}.
Who Should Try Them?
- Adults (22+) on medication or therapy seeking extra support.
- Those facing barriers to in-person therapy.
- People wanting daily tools to practice mental health skills.
Possible Drawbacks
While promising, digital therapeutics aren't magic:
- Not meant to replace therapy or medication :contentReference[oaicite:11]{index=11}.
- Effectiveness varies and long-term data is limited :contentReference[oaicite:12]{index=12}.
- User engagement may decline over time :contentReference[oaicite:13]{index=13}.
FAQs
- Do I need a prescription? Yes—Rejoyn is prescription-only and must be part of a treatment plan.
- Is it safe? Yes—it underwent FDA review and clinical trials :contentReference[oaicite:14]{index=14}.
- Can I try it on my own? No—only with a provider’s guidance.
Final Takeaway
Digital therapeutics like Rejoyn are changing depression care—bringing CBT-based brain training into everyday life. They add an extra layer of support to traditional treatment, helping people manage depression more effectively. If you're struggling and want more tools, ask your provider whether a digital prescription is right for you.